BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30631005)

  • 21. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
    Li MM; Tang YQ; Gong YF; Cheng W; Li HL; Kong FE; Zhu WJ; Liu SS; Huang L; Guan XY; Ma NF; Liu M
    BMC Cancer; 2019 Aug; 19(1):851. PubMed ID: 31462277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.
    Tian MX; Liu WR; Wang H; Zhou YF; Jin L; Jiang XF; Tao CY; Tang Z; Zhou PY; Fang Y; Qu WF; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Lau WY; Fan J; Shi YH
    BMC Med; 2019 Jun; 17(1):106. PubMed ID: 31164128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
    Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
    Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
    Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
    Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
    Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
    Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prognostic biomarkers for patients with hepatocellular carcinoma after hepatectomy.
    Wang X; Liao X; Yang C; Huang K; Yu T; Yu L; Han C; Zhu G; Zeng X; Liu Z; Zhou X; Qin W; Su H; Ye X; Peng T
    Oncol Rep; 2019 Mar; 41(3):1586-1602. PubMed ID: 30628708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
    Qiu X; Huang Y; Zhou Y; Zheng F
    Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma.
    Lai X; Wu YK; Hong GQ; Li JK; Luo Q; Yuan J; Dai GH; Liu SQ; Feng HG
    J Immunol Res; 2022; 2022():9117205. PubMed ID: 35402624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The landscape of DNA methylation in hepatocellular carcinoma.
    Zheng YF; Lu X; Zhang XY; Guan BG
    J Cell Physiol; 2019 Mar; 234(3):2631-2638. PubMed ID: 30145793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
    Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
    BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
    Li G; Xu W; Zhang L; Liu T; Jin G; Song J; Wu J; Wang Y; Chen W; Zhang C; Chen X; Ding Z; Zhu P; Zhang B
    EBioMedicine; 2019 Sep; 47():128-141. PubMed ID: 31492561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
    Shao Y; Zhang D; Li X; Yang J; Chen L; Ning Z; Xu Y; Deng G; Tao M; Zhu Y; Jiang J
    Mol Pharm; 2018 Aug; 15(8):3205-3215. PubMed ID: 29906128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.